Alicaforsen regulatory update

FDA granted Orphan Drug designation to Atlantic Healthcare's alicaforsen (AP 1007) to treat pouchitis. The antisense inhibitor of ICAM-1 ( CD54) is expected to start Phase III testing for the indicat...